Cannabinoid CB1 receptor-mediated inhibition of prolactin release and signaling mechanisms in GH4C1 cells

Endocrinology

Volumn 141, Issue 5, 2000, Pages 1675-1685

  Ho, Begonia Y ^a   Stadnicka, Anna ^b   Prather, Paul L ^c   Buckley, Arthur R ^d   Current, Lori L ^a   Bosnjak, Zeljko J ^b   Kwok, Wai Meng ^b  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ADENYLATE CYCLASE; ANILINE DERIVATIVE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CANNABINOID 1 RECEPTOR; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE; OMEGA CONOTOXIN; PERTUSSIS TOXIN; PROLACTIN; PROTEIN SUBUNIT; RIMONABANT; THYROTROPIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CELL LINE; CONTROLLED STUDY; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROLACTIN RELEASE; PROTEIN FAMILY; RAT; SIGNAL TRANSDUCTION;

EID: 0034455309     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.5.7454     Document Type: Article

References (50)

1. Pharmacology of cannabinoid receptors
2. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion
3. Molecular cloning of a human cannabinoid receptor which is also expressed in testis
4. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
5. Molecular characterization of a peripheral receptor for cannabinoids
6. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
7. 2+ in rat lactotrophs
8. 2+
9. Voltage-dependent calcium channels in pituitary cells in culture. II. Participation in thyrotropin-releasing hormone action on prolactin release
10. Mechanisms of action of somatostatin on human TSH-secreting adenoma cells
11. 3 pituitary cells, acetylcholine and vasoactive intestinal peptide antagonistically modulate adenylate cyclase, cyclic AMP content, and prolactin secretion
12. The intrinsic activity of (-)-3-PPP vis-a-vis prolactin-suppressing dopamine D2 receptors in transfected GH4C1 cells is dependent on which secretagogue that is used to provoke prolactin release
13. 3 cells
14. Effects of cannabinoids on prolactin and gonadotrophin secretion: Involvement of changes in hypothalamic γ-aminobutyric acid (GABA) inputs
15. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: Evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics
16. 9-tetrahydrocannabinol in nonhuman primates
17. 9-tetrahydrocannabinol action
18. 1 cells
19. 1 pituitary cells
20. i subtype specificity of the 5-HT1A receptor
21. s-mediated cAMP accumulation and calcium mobilization by dopamine D2S receptors
22. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones
23. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors
24. Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism
25. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells
26. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells
27. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons
28. The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons
29. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor
30. Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes
31. + channels
32. A new sensitive and specific bioassay for lactogenic hormones: Measurement of prolactin and growth hormone in human serum
33. Inhibition by genistein of prolactin-induced Nb2 lymphoma cell mitogenesis
34. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
35. Interaction of δ-opioid receptors with multiple G proteins: A non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins
36. Ability of δ-opioid receptors to interact with multiple G-proteins is independent of receptor density
37. Preparation of cyclic nucleotide antisera with thyroglobulin-cyclic nucleotide conjugates
38. Gα15 and Gα16 couple a wide variety of receptors to phospholipase C
39. 2-adrenergic inhibition of adenylyl cyclase in platelet membranes: In situ identification with Gα C-terminal antibodies
40. Antibodies as probes of G-protein receptor-effector coupling and of G-protein membrane attachment
41. μ and δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells
42. Identification of three separate guanine nucleotide-binding proteins that interact with the δ-opioid receptor in NG108-15 neuroblastoma X glioma hybrid cells
43. Diversity of G proteins in signal transduction
44. Calcium channel diversity and neurotransmitter release: The ω-conotoxins and ω-agatoxins
45. 3 cells
46. 2+ channel current
47. + channels by Gk is mediated by its α-subunit
48. Direct coupling of the somatostatin receptor to potassium channels by a G protein
49. Reversal of inhibition of prolactin secretion in cultured pituitary cells by muscarinic antagonists
50. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents